TrialThe Journal of international medical research2023

Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis.

Ge Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.